FSD Pharma Announces Appointments of Dr. Raza Bokhari as Interim CEO and Co-Chairman, Anthony Durkacz as Co-Chairman and Zeeshan Saeed as President
FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments, to Create Medical Cannabis Industry Innovator
Syntholene Energy Corp. Announces Engagement of DS Market Solutions Inc. for Liquidity Services and Emerging Markets Consulting for Communications and Marketing Services
